Schering Clarification On Market Research Requested By FDA
Executive Summary
Schering-Plough is telling doctors how to distinguish legitimate focus group market research from "promotion under the guise of market research" as part of a corrective action plan undertaken by the company in response to a July 31 warning letter from FDA.